The future of HIV is here

United Nations Secretary-General Ban Ki-moon recently declared that the world will soon welcome a “generation free of AIDS”. His bold statement followed the release of latest UNAIDS research showing that across the globe new HIV infections have fallen by 35% and AIDS-related deaths by 41% since 2000.

Initiatives to reduce HIV transmission focus heavily on the use of anti-retroviral (ART) medication – a strategy known as ‘Treatment as Prevention’ or TasP. There are two aspects to TasP.

The first aspect is a course of ART medication that can be taken by HIV negative people before or after sex to prevent them acquiring HIV. The second is ART medication for people living with HIV.

ART is the great success story of HIV treatment. Access to ART means a person with HIV can expect to live a long, healthy life and that they will be much less likely to transmit HIV to others.

If most Australians living with HIV are using ART, and there is a continued emphasis on safe sex and safe drug use, then Australia is in a good position to achieve the 2020 goals.

However, the social reality is more complicated.

TasP means that prevention initiatives place emphasise the actions of people living with HIV. This potentially detracts from the sense of ‘shared responsibility’ for HIV prevention that characterised safe-sex campaigns.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below